Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.05 GBP
30.28 M GBP
505.78 M GBP
500.47 M
About HUTCHMED (CHINA) LIMITED
Sector
Industry
CEO
Wei Guo Su
Website
Headquarters
Hong Kong
Founded
2000
FIGI
BBG000VY2PV8
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
HCM Learning experiencePlaying Trading Simulator:
Big time rookie mistake.
Bought 350 shares at $41.71 on 3JAN18. Price was falling.
Same day bought 500 shares at $39.93 in order to dilute my buying price.
I began studying the chart and saw my mistake.
On 5JAN18 I sold my shares using a trailing stop of 10 cents.
It exe
Tracking HCMI've been a long term holder of HCM since 2009. They are also listed on the FTSE AIM 100 LSE:HCM.
They have outperformed the NASDAQ BIOTECHNOLOGY INDEX INDEX:NBI
Now would be a good place to exit.
I will continue to hold for now, i am not trading this. It's included in my long term portfolio.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of HCM.GB is 234.30 GBX — it has increased by 10.30% in the past 24 hours. Watch HUTCHMED (CHINA) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AQUIS exchange HUTCHMED (CHINA) stocks are traded under the ticker HCM.GB.
HCM.GB stock has risen by 15.41% compared to the previous week, the month change is a 4.79% rise, over the last year HUTCHMED (CHINA) has showed a −19.48% decrease.
We've gathered analysts' opinions on HUTCHMED (CHINA) future price: according to them, HCM.GB price has a max estimate of 593.04 GBX and a min estimate of 231.67 GBX. Watch HCM.GB chart and read a more detailed HUTCHMED (CHINA) stock forecast: see what analysts think of HUTCHMED (CHINA) and suggest that you do with its stocks.
HCM.GB reached its all-time high on Jul 29, 2021 with the price of 626.25 GBX, and its all-time low was 132.55 GBX and was reached on Oct 24, 2022. View more price dynamics on HCM.GB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HCM.GB stock is 9.34% volatile and has beta coefficient of 0.73. Track HUTCHMED (CHINA) stock price on the chart and check out the list of the most volatile stocks — is HUTCHMED (CHINA) there?
Today HUTCHMED (CHINA) has the market capitalization of 2.22 B, it has increased by 7.44% over the last week.
Yes, you can track HUTCHMED (CHINA) financials in yearly and quarterly reports right on TradingView.
HUTCHMED (CHINA) is going to release the next earnings report on Aug 4, 2025. Keep track of upcoming events with our Earnings Calendar.
HCM.GB earnings for the last half-year are 0.01 GBX per share, whereas the estimation was 0.01 GBX, resulting in a 75.00% surprise. The estimated earnings for the next half-year are 0.21 GBX per share. See more details about HUTCHMED (CHINA) earnings.
HUTCHMED (CHINA) revenue for the last half-year amounts to 259.39 M GBX, despite the estimated figure of 255.18 M GBX. In the next half-year revenue is expected to reach 241.20 M GBX.
HCM.GB net income for the last half-year is 9.55 M GBP, while the previous report showed 20.43 M GBP of net income which accounts for −53.24% change. Track more HUTCHMED (CHINA) financial stats to get the full picture.
No, HCM.GB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 14, 2025, the company has 1.81 K employees. See our rating of the largest employees — is HUTCHMED (CHINA) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUTCHMED (CHINA) EBITDA is −25.19 M GBP, and current EBITDA margin is −5.18%. See more stats in HUTCHMED (CHINA) financial statements.
Like other stocks, HCM.GB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUTCHMED (CHINA) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUTCHMED (CHINA) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUTCHMED (CHINA) stock shows the sell signal. See more of HUTCHMED (CHINA) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.